Amneal Pharmaceuticals, Inc. (AMRX)
20.30
+0.23
(+1.15%)
USD |
NASDAQ |
Oct 02, 16:00
20.44
+0.14
(+0.69%)
After-Hours: 20:00
Amneal Pharmaceuticals Profit Margin (Quarterly) : 8.74% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.74% |
| March 31, 2026 | 10.80% |
| December 31, 2025 | 6.09% |
| September 30, 2025 | 2.31% |
| June 30, 2025 | 4.92% |
| March 31, 2025 | 3.54% |
| December 31, 2024 | -2.84% |
| September 30, 2024 | 1.67% |
| June 30, 2024 | 2.39% |
| March 31, 2024 | -12.39% |
| December 31, 2023 | -15.13% |
| September 30, 2023 | 4.04% |
| June 30, 2023 | 4.96% |
| March 31, 2023 | -1.81% |
| December 31, 2022 | -0.96% |
| September 30, 2022 | -0.44% |
| June 30, 2022 | -42.92% |
| March 31, 2022 | -1.30% |
| December 31, 2021 | -3.81% |
| September 30, 2021 | -1.15% |
| June 30, 2021 | 6.01% |
| March 31, 2021 | 2.95% |
| December 31, 2020 | -1.36% |
| September 30, 2020 | -4.24% |
| June 30, 2020 | -5.15% |
| Date | Value |
|---|---|
| March 31, 2020 | 24.37% |
| December 31, 2019 | -16.33% |
| September 30, 2019 | -96.06% |
| June 30, 2019 | -12.49% |
| March 31, 2019 | -27.96% |
| December 31, 2018 | -4.09% |
| September 30, 2018 | 3.67% |
| June 30, 2018 | -12.02% |
| March 31, 2018 | 0.04% |
| December 31, 2017 | 0.21% |
| September 30, 2017 | 0.13% |
| June 30, 2017 | 0.12% |
| March 31, 2017 | |
| December 31, 2016 | -140.9% |
| September 30, 2016 | -78.69% |
| June 30, 2016 | -1.56% |
| March 31, 2016 | -4.62% |
| December 31, 2015 | 4.05% |
| September 30, 2015 | 16.17% |
| June 30, 2015 | -0.86% |
| March 31, 2015 | -4.43% |
| December 31, 2014 | 0.09% |
| September 30, 2014 | 9.96% |
| June 30, 2014 | 18.64% |
| March 31, 2014 | 5.41% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Liquidia Corp. | 43.52% |
| Eli Lilly & Co. | 30.88% |
| Johnson & Johnson | 21.86% |
| Merck & Co., Inc. | -8.06% |
| Viatris, Inc. | -3.16% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 1.46K% |
| Return on Assets | 5.98% |
| Return on Invested Capital | 7.96% |
| Gross Profit Margin (Quarterly) | 42.01% |
| Operating Margin (Quarterly) | 18.43% |
| Return on Net Operating Assets | 6.51% |